In a report released yesterday, Benjamin Rossi from J.P. Morgan maintained a Hold rating on Universal Health, with a price target of $205.00. The company’s shares closed yesterday at $157.80.Meet Samuel – Your Personal Investing ProphetStart a conversation with TipRanks’ trusted, data-backed investment intelligence
Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
According to TipRanks, Rossi is an analyst with an average return of -4.0% and a 43.75% success rate. Rossi covers the Healthcare sector, focusing on stocks such as Universal Health, US Physical Therapy, and Tenet Healthcare.
Universal Health has an analyst consensus of Moderate Buy, with a price target consensus of $222.54, implying a 41.03% upside from current levels. In a report released on May 21, Morgan Stanley also maintained a Hold rating on the stock with a $212.00 price target.
Based on Universal Health’s latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $4.5 billion and a net profit of $348.68 million. In comparison, last year the company earned a revenue of $4.1 billion and had a net profit of $316.68 million
